Valuation: Bould Opportunities PLC

Market Cap 5.71K 5.01K 4.73K 4.31K 8.07K 547K 8.13K 56.6K 21.92K 279K 21.43K 20.96K 898K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -68.7K -64.89K -59.13K -111K -7.5M -111K -776K -301K -3.83M -294K -288K -12.32M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 2021-05-13
Chief Tech/Sci/R&D Officer 61 2025-01-01
Director TitleAgeSince
Director/Board Member 45 2019-01-28
Chairman 70 2019-05-20
Director/Board Member 61 2021-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+24.32% - - 3.54M
+2.73%+4.90%-4.91%+92.24% 9.2B
-5.66%-0.49%+264.41%+259.20% 2.47B
+0.58%+3.95%-31.72%-37.89% 2.09B
-0.41%0.00%-16.04%-30.48% 1.61B
+2.94%+19.02%+123.56% - 1.2B
+4.01%+16.55%+88.17%+77.34% 1.04B
-0.20%0.00%-24.38%-11.71% 975M
+0.88%+3.86%-10.71%+34.70% 758M
-0.39%-0.26%+18.61%+108.72% 743M
Average +0.46%+5.73%+45.22%+61.51% 2.01B
Weighted average by Cap. +0.97%+3.23%+36.74%+81.39%

Financials

2019 2020
Net sales - -
Net income -832K -730K -690K -628K -1.18M -79.74M -1.18M -8.25M -3.2M -40.74M -3.12M -3.06M -131M -306K -269K -254K -231K -433K -29.33M -436K -3.03M -1.18M -14.98M -1.15M -1.12M -48.15M
Net Debt -378K -332K -313K -285K -534K -36.23M -538K -3.75M -1.45M -18.51M -1.42M -1.39M -59.49M -84K -73.71K -69.62K -63.44K -119K -8.05M -120K -833K -323K -4.11M -315K -309K -13.22M
Logo Bould Opportunities PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-